Published in Adv Shock Res on January 01, 1979
Human alveolar macrophage fibronectin: synthesis, secretion, and ultrastructural localization during gelatin-coated latex particle binding. J Cell Biol (1981) 1.32
Plasma fibronectin and associated variables in surgical intensive care patients. Ann Surg (1983) 0.93
The influence of fibronectin administration on the incidence of sepsis and septic mortality in severely injured patients. The Medical College of Georgia Fibronectin Research Group. Ann Surg (1989) 0.87
Purified fibronectin administration to patients with severe abdominal infections. A controlled clinical trial. Ann Surg (1985) 0.83
Chronic fatigue syndrome: a working case definition. Ann Intern Med (1988) 9.12
Epidemiology of Norwalk gastroenteritis and the role of Norwalk virus in outbreaks of acute nonbacterial gastroenteritis. Ann Intern Med (1982) 4.54
The frequency of a Norwalk-like pattern of illness in outbreaks of acute gastroenteritis. Am J Public Health (1982) 3.78
Acquired immunodeficiency syndrome (AIDS) associated with transfusions. N Engl J Med (1984) 3.22
Plasma fibronectin (opsonic glycoprotein): its synthesis by vascular endothelial cells and role in cardiopulmonary integrity after trauma as related to reticuloendothelial function. Am J Med (1980) 2.75
Physiology and physiopathology of the reticuloendothelial system. Arch Intern Med (1970) 2.72
HIV risk factors in three geographic strata of rural Rakai District, Uganda. AIDS (1992) 2.41
Detection of Norwalk virus antibodies and antigen with a biotin-avidin immunoassay. J Clin Microbiol (1985) 2.28
Biochemical and immunological characterization of human opsonic alpha2SB glycoprotein: its identity with cold-insoluble globulin. J Biol Chem (1978) 2.05
Physiologic role of cold-insoluble globulin in systemic host defense: implications of its characterization as the opsonic alpha 2-surface-binding glycoprotein. Ann N Y Acad Sci (1978) 1.86
Surveillance for AIDS-defining opportunistic illnesses, 1992-1997. MMWR CDC Surveill Summ (1999) 1.81
A cluster of patients with a chronic mononucleosis-like syndrome. Is Epstein-Barr virus the cause? JAMA (1987) 1.75
Cryoprecipitate reversal of opsonic alpha2-surface binding glycoprotein deficiency in septic surgical and trauma patients. Science (1978) 1.73
Seroprevalence of HTLV-1 and HTLV-2 among intravenous drug users and persons in clinics for sexually transmitted diseases. N Engl J Med (1992) 1.56
Reference sample method for cardiac output and regional blood flow determinations in the rat. J Appl Physiol (1976) 1.52
An international collaborative study of the effects of coinfection with human T-lymphotropic virus type II on human immunodeficiency virus type 1 disease progression in injection drug users. J Infect Dis (1996) 1.51
Opsonic alpha2 surface binding glycoprotein therapy during sepsis. Ann Surg (1978) 1.49
Gastroenteritis due to Norwalk virus: an outbreak associated with a municipal water system. J Infect Dis (1982) 1.49
An outbreak of acute nonbacterial gastroenteritis in a nursing home. Demonstration of person-to-person transmission by temporal clustering of cases. Am J Epidemiol (1982) 1.46
Fibronectin as a co-factor necessary for optimal granulocyte phagocytosis of Staphylococcus aureus. J Reticuloendothel Soc (1981) 1.45
Evaluation of a rapid immunoturbidimetric assay for opsonic fibronectin in surgical and trauma patients. J Lab Clin Med (1981) 1.44
Method for collection and determination of 14CO-2 for in vitro metabolic studies. J Lipid Res (1966) 1.44
Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination. Clin Infect Dis (2001) 1.44
Reticuloendothelial blockade and recovery as a function of opsonic activity. Am J Physiol (1969) 1.42
Characterization of antibody reactivity to human T-cell lymphotropic virus types I and II using immunoblot and radioimmunoprecipitation assays. J Clin Microbiol (1990) 1.40
Opsonic glycoprotein (plasma fibronectin) levels after burn injury. Relationship to extent of burn and development of sepsis. Ann Surg (1980) 1.37
Isolation of human T-cell lymphotropic virus type 2 from Guaymi Indians in Panama. Proc Natl Acad Sci U S A (1990) 1.36
Phylogenetic relationship and geographic distribution of multiple human T-cell lymphotropic virus type II subtypes. J Virol (1995) 1.33
Purification of alpha-2-opsonic protein from human serum and its measurement by immunoassay. J Reticuloendothel Soc (1978) 1.26
Guillain-Barré syndrome in the United States, 1979-1980 and 1980-1981. Lack of an association with influenza vaccination. JAMA (1982) 1.22
Sensitive and specific polymerase chain reaction assays for diagnosis of human T-cell lymphotropic virus type I (HTLV-I) and HTLV-II infections in HTLV-I/II-seropositive individuals. J Clin Microbiol (1992) 1.19
Effect of surgical trauma on the clearance and localization of blood-borne particulate matter. Surgery (1972) 1.18
Isolation and biochemical characterization of alpha-2-opsonic glycoprotein from rat serum. J Biol Chem (1977) 1.16
Humoral deficiency and reticuloendothelial depression after traumatic shock. Am J Physiol (1976) 1.16
Longitudinal evaluation of neuropsychological function in homosexual men with HIV infection: 18-month follow-up. J Neuropsychiatry Clin Neurosci (1991) 1.14
Humoral recognition deficiency in the etiology of reticuloendothelial depression induced by surgery. Ann Surg (1973) 1.14
Hepatocyte injury during post-operative sepsis: activated neutrophils as potential mediators. J Leukoc Biol (1988) 1.13
Normal fibronectin levels as a function of age in the pediatric population. Pediatr Res (1983) 1.11
HTLV-II endemicity among Guaymi Indians in Panama. N Engl J Med (1991) 1.10
Synthetic peptide-based immunoassays for distinguishing between human T-cell lymphotropic virus type I and type II infections in seropositive individuals. J Clin Microbiol (1991) 1.10
Antibody response to human immunodeficiency virus in homosexual men. Relation of antibody specificity, titer, and isotype to clinical status, severity of immunodeficiency, and disease progression. J Clin Invest (1987) 1.09
Cardiovascular hemodynamics after opsonic alpha-2-surface binding glycoprotein therapy in injured patients. Surgery (1979) 1.08
Mechanism of acute depletion of plasma fibronectin following thermal injury in rats. Appearance of a gelatinlike ligand in plasma. J Clin Invest (1984) 1.07
Complete nucleotide sequence of an Amerindian human T-cell lymphotropic virus type II (HTLV-II) isolate: identification of a variant HTLV-II subtype b from a Guaymi Indian. J Virol (1993) 1.07
The sensitivity of various serologic tests in the diagnosis of Rocky Mountain spotted fever. Am J Trop Med Hyg (1986) 1.06
Decreased resistance to intravenous tumour-cell challenge during reticuloendothelial depression following surgery. Br J Cancer (1976) 1.06
Involvement of the opsonic system in starvation induced depression of the reticuloendothelial system. Proc Soc Exp Biol Med (1968) 1.06
Trends in AIDS-related opportunistic infections among men who have sex with men and among injecting drug users, 1991-1996. J Infect Dis (1998) 1.05
Incidence and risk factors for human T-lymphotropic virus type II seroconversion among injecting drug users in Baltimore, Maryland, U.S.A. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.05
Comparative disappearance and localization of isotopically labeled opsonic protein and soluble albumin following surgical trauma. J Reticuloendothel Soc (1976) 1.05
Evaluation of an immunoblot assay for serological confirmation and differentiation of human T-cell lymphotropic virus types I and II. J Clin Microbiol (1993) 1.04
The syndrome of unexplained generalized lymphadenopathy in young men in New York City. Is it related to the acquired immune deficiency syndrome? JAMA (1984) 1.04
Purification and biochemical characterization of a macrophage stimulating alpha-2-globulin opsonic protein. J Reticuloendothel Soc (1976) 1.04
Accuracy of supplementary serologic testing for human T-lymphotropic virus types I and II in US blood donors. Retrovirus Epidemiology Donor Study. Blood (1994) 1.03
Unexplained lymphadenopathy in homosexual men. A longitudinal study. JAMA (1985) 1.03
Isolation, purification and characterization of opsonic protein. J Reticuloendothel Soc (1973) 1.03
Prevention of liver reticuloendothelial systemic host defense failure after surgery by intravenous opsonic glycoprotein therapy. Ann Surg (1978) 1.02
25- to 30-nm virus particle associated with a hospital outbreak of acute gastroenteritis with evidence for airborne transmission. Am J Epidemiol (1988) 1.02
Evaluation of a recombinant human T-cell lymphotropic virus type I (HTLV-I) p21E antibody detection enzyme immunoassay as a supplementary test in HTLV-I/II antibody testing algorithms. J Clin Microbiol (1991) 1.01
Guillain-Barré syndrome in the United States, 1978-1981: additional observations from the national surveillance system. Neurology (1983) 1.01
Immune complexes in the acquired immunodeficiency syndrome (AIDS): relationship to disease manifestation, risk group, and immunologic defect. J Clin Immunol (1985) 0.99
Poliomyelitis in the USA: virtual elimination of disease caused by wild virus. Lancet (1984) 0.99
Effect of fibronectin fragments on macrophage phagocytosis of gelatinized particles. J Immunol (1984) 0.98
Deficits in reticuloendothelial humoral control mechanisms in patients after trauma. J Trauma (1976) 0.97
Influence of gelatin on bioassayable and immunoreactive opsonic fibronectin. Proc Soc Exp Biol Med (1981) 0.97
Pulmonary neutrophil kinetics after thrombin-induced intravascular coagulation. J Appl Physiol Respir Environ Exerc Physiol (1984) 0.97
Opsonic fibronectin after trauma and particle injection determined by a peritoneal macrophage monolayer assay. J Reticuloendothel Soc (1981) 0.97
Reticuloendothelial systemic response to operative trauma as influenced by cryoprecipitate or cold-insoluble globulin therapy. J Reticuloendothel Soc (1979) 0.96
Disturbances in circulating opsonic activity in man after operative and blunt trauma. J Surg Res (1977) 0.96
Risk for preventable opportunistic infections in persons with AIDS after antiretroviral therapy increases CD4+ T lymphocyte counts above prophylaxis thresholds. J Infect Dis (2000) 0.96
Epidemiologic investigations of dengue infection in Mexico, 1980. Am J Epidemiol (1983) 0.95
Humoral mediated macrophage response during tumour growth. Br J Cancer (1975) 0.95
Increased recycling of (alpha)5(beta)1 integrins by lung endothelial cells in response to tumor necrosis factor. J Cell Sci (2000) 0.95
Opsonic fibronectin deficiency and sepsis. Cause or effect? Ann Surg (1982) 0.94
Dynamics of insulin secretion and resistance after burns. J Trauma (1977) 0.94
Vascular clearance and metabolism of lipid by the reticuloendothelial system in dogs. Am J Physiol (1971) 0.94
Kinetics of endogenously labeled plasma fibronectin: incorporation into tissues. Am J Physiol (1983) 0.92
Role of platelets in maintenance of pulmonary vascular permeability to protein. Am J Physiol (1988) 0.92
The effect of immune globulin on the response to trivalent oral poliovirus and yellow fever vaccinations. Bull World Health Organ (1984) 0.92
Coccidioidomycosis among persons with AIDS in the United States. J Infect Dis (1995) 0.92
An affinity method for the rapid purification of opsonic alpha 2 SB glycoprotein from serum. Adv Shock Res (1979) 0.91
Isolation of an amino-terminal fibronectin-binding protein on human U937 cells and rat peritoneal macrophages. J Biol Chem (1992) 0.91
Low-grade intravascular coagulation and reticuloendothelial function. Am J Physiol (1978) 0.91
Bioassay of serum opsonin and its depletion after colloid clearance in dogs. Am J Physiol (1972) 0.90
Reintroduction of dengue fever into the continental United States. I. Dengue surveillance in Texas, 1980. Am J Trop Med Hyg (1982) 0.90
Guillain-Barré syndrome in Larimer County, Colorado: a high-incidence area. Neurology (1985) 0.90
Surgical stess and reticuloendothelial function. Surgery (1969) 0.90
Fibronectin fragments released from phorbol ester-stimulated pulmonary artery endothelial cell monolayers promote neutrophil chemotaxis. Immunology (1991) 0.90
Von Willebrand factor (VIII R:Ag), fibronectin, and insulin-like growth factors I and II in diabetic retinopathy and nephropathy. Diabetes (1984) 0.89
Electroimmunoassay of alpha-2-opsonic protein during reticuloendothelial blockade. Am J Physiol (1977) 0.89
Lack of correlation between human herpesvirus-6 infection and the course of human immunodeficiency virus infection. J Infect Dis (1990) 0.89
Reversal of fibronectin and opsonic deficiency in patients. A controlled study. Ann Surg (1984) 0.89